Cover Image: March 2010 Scientific American Magazine See Inside

New Hope for Battling Brain Cancer [Preview]

Studies suggest that stem cells sustain deadly tumors in the brain—and that aiming at these insidious culprits could lead to a cure














Share on Tumblr

In Brief

  • More than 25,000 Americans are diagnosed with a malignant ­glioma every year. About 60 to 70 percent of these cancers occur in the deadliest form, glioblastoma, the type that took the life of Massachusetts Senator Edward Kennedy in August of 2009, 15 months after he was diagnosed.
  • Although medical science has made significant progress in treating several other cancers, the U.S. Food and Drug Administration has approved only three new drugs that treat brain cancer in the past 35 years, and these prolong lives by only a few months. The life expectancy of a person diagnosed with glioblastoma remains 12 to 14 months, roughly the same as it was a century ago.
  • The discovery and characterization of a tiny population of tumor-regenerating stem cells within brain tumors brings new hope that these deadly cancers can be successfully treated, possibly with drugs that are already on pharmacy shelves.

In May 2006 Dwayne Berg woke up on a gurney in a Seattle emergency room, an IV in his arm and a team of doctors and nurses working him up. The last thing the 42-year-old financial executive could remember was running on a treadmill at his gym, part of his regular fitness regimen. He had suffered a seizure and tumbled off the machine, and although he had not hurt himself in the fall, doctors had asked for an MRI scan of his brain to see if they could find a cause for the seizure.

They did, and the news was not good: the scan showed a large mass in the left frontal lobe that turned out to be a malignant glioma, a brain cancer that is almost invariably fatal. Berg underwent standard treatment: an operation to remove the tumor, followed by chemotherapy and radiation to eradicate any cancer cells that might remain.


This article was originally published with the title New Hope for Battling Brain Cancer.



Buy This Issue
If your institution has site license access, enter here.
Rights & Permissions

3 Comments

Add Comment
View
  1. 1. popartpopart 10:22 PM 3/14/10

    should have came up with this shit 4 years ago

    Reply | Report Abuse | Link to this
  2. 2. popartpopart 10:23 PM 3/14/10

    should have came up with this shit 4 years ago

    Reply | Report Abuse | Link to this
  3. 3. alexsom 03:28 AM 1/7/11

    Brain cancer is among one of the deadliest forms of cancer. If it caught early stage it can be save the life but if caught in Stage IV, which has a low recovery rate. Early detection, however, can help discovery of brain tumors long before they reach Stage IV. Symptoms of early stage tumors in the frontal lobe will cause pain in the front of the head, and possibly slight memory impairment.
    http://www.biblehealth.com/brain-cancer/types-of-brain-cancer-determines-the-life-threatening-aspect.html

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Email this Article

New Hope for Battling Brain Cancer: Scientific American Mind

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X